miR-22 suppresses DNA ligase III addiction in multiple myeloma (Q91013801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

title

miR-22 suppresses DNA ligase III addiction in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

author

Maria Teresa Di Martino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Pierfrancesco Tassone

object named as

Pierfrancesco Tassone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Pierosandro Tagliaferri

object named as

Pierosandro Tagliaferri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Daniele Caracciolo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Nicola Amodio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Martina Montesano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Francesca Scionti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Daniela Talarico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Emanuela Altomare

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Maria Eugenia Gallo Cantafio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Valeria Zuccalà

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Lorenza Maltese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Katia Todoerti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Mariamena Arbitrio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

publication date

17 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

page(s)

487-498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

18 April 2020

start time

17 August 2018

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Genomic instability in multiple myeloma: mechanisms and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Pathogenesis of Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

The genetic architecture of multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Dysfunctional homologous recombination mediates genomic instability and progression in myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Eukaryotic DNA ligases: structural and functional insights

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

DNA ligase I, the replicative DNA ligase

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

The human DNA ligase III gene encodes nuclear and mitochondrial proteins

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

DNA ligase III as a candidate component of backup pathways of nonhomologous end joining

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

An alternative splicing event which occurs in mouse pachytene spermatocytes generates a form of DNA ligase III with distinct biochemical properties that may function in meiotic recombination

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

DNA damage response regulation by microRNAs as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Targeting microRNAs in cancer: rationale, strategies and challenges

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

MicroRNAs as potential cancer therapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

miR-34 - a microRNA replacement therapy is headed to the clinic

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

The molecular classification of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

NAViGaTing the micronome--using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Advances in biology of multiple myeloma: clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Prognostic significance of copy-number alterations in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Targeting abnormal DNA repair in therapy-resistant breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Mitochondria and Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Antisense-mediated decrease in DNA ligase III expression results in reduced mitochondrial DNA integrity

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Mitochondrial DNA ligase is dispensable for the viability of cultured cells but essential for mtDNA maintenance

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Widespread microRNA repression by Myc contributes to tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Emerging roles of microRNA-22 in human disease and normal physiology

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Mitochondrial modulation decreases the bortezomib-resistance in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FS41375-018-0238-2

7 January 2021

10.1038/S41375-018-0238-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

PubMed publication ID

30120376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30120376%20AND%20SRC:MED&resulttype=core&format=json